Larimar Therapeutics, Inc. (LRMR) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -44.61M | -38.53M | -28.75M | -19.38M | -26.54M | -21.82M | -24.55M | -13.99M | -10.41M | -9.34M | -9.2M | -7.37M | -7.55M | -6.67M | -5.88M | -7.49M | -7.53M | -7.92M | -12.2M | -10.78M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -68.1% | -76.61% | -17.14% | -38.55% | -154.92% | -133.49% | -166.8% | -89.93% | -37.88% | -40.03% | -56.52% | 1.62% | -0.24% | 15.74% | 51.82% | 30.57% | 32.78% | 19.67% | -8.71% | 11.62% |
| Net Income | -29.61M | -62.5M | -47.71M | -26.18M | -29.28M | -28.82M | -15.5M | -21.63M | -14.65M | -12.99M | -9.06M | -8.37M | -6.53M | -9.43M | -8.32M | -8.67M | -8.94M | -9.13M | -16.8M | -12.61M |
| Depreciation & Amortization | 0 | 87K | 88K | 87K | -667K | 77K | 74K | 87K | 80K | 81K | 69K | 76K | 78K | 78K | 77K | 81K | 82K | 88K | 88K | 77K |
| Stock-Based Compensation | 0 | 0 | 1.78M | 1.83M | 1.83M | 2.41M | 1.96M | 2.3M | 2.13M | 1.92M | 0 | 2.04M | 1.83M | 1.64M | 0 | 1.68M | 1.64M | 1.48M | 1.46M | 1.35M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.55M | 0 | -29K | 0 | 0 | 0 | 0 | 5K | 0 | 0 | 0 |
| Other Non-Cash Items | 1.88M | 1.32M | -394K | -534K | -60K | -1.24M | -1.76M | -1.82M | -626K | 896K | 1.26M | -27K | -640K | -754K | 1.6M | -3K | -5K | -2K | -7K | -1K |
| Working Capital Changes | -16.88M | 22.56M | 17.48M | 5.42M | 1.63M | 5.76M | -9.32M | 7.07M | 2.66M | 2.31M | -1.46M | -1.06M | -2.3M | 1.79M | 762K | -572K | -307K | -350K | 3.06M | 401K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 2.92M | -5.83M | 6.9M | 1.87M | -150K | 738K | -1.22M | 1.34M | 290K | 527K | -1.59M | 1.65M | -991K | 917K | 344K | -1.89M | 657K | -97K | 589K | -2.03M |
| Cash from Investing | 29M | 34M | 33.02M | 18.84M | 14.45M | 19.2M | 27.27M | -63.49M | -68.36M | -2.63M | -46.43M | -9.84M | 92.25M | -52.23M | -3.38M | -35.34M | 0 | 6.49M | -6.79M | 19.22M |
| Capital Expenditures | 0 | 0 | -23K | -19K | -49K | -179K | -62K | -274K | 0 | -164K | 0 | 0 | 0 | 0 | 0 | -100K | 0 | -9K | -293K | -31K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.46K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.46K | 0 | -9.84K | 92.25K | -52.23K | 0 | -35.24K | 0 | 6.5K | -6.5K | 19.25K |
| Cash from Financing | 108.11M | -201K | 65.29M | 0 | 0 | 36K | 30K | -334K | 162.15M | 0 | 30K | 0 | 0 | -316K | 75.57M | 0 | 0 | 0 | 19.89M | 0 |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 108.11M | -201K | 65.29M | 0 | 0 | 36K | 30K | -345K | 162.15M | 0 | 30K | 0 | 0 | -316K | 75.57M | 0 | 0 | 0 | 19.89M | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 92.5M | -4.73M | 69.55M | -539K | -12.09M | -2.58M | 2.76M | -77.81M | 83.38M | -11.97M | -55.6M | -17.2M | 84.7M | -59.22M | 66.31M | -42.83M | -7.53M | -1.43M | 895K | 8.44M |
| Free Cash Flow | -44.61M | -38.53M | -28.78M | -19.4M | -26.59M | -21.99M | -24.61M | -14.26M | -10.41M | -9.51M | -9.2M | -7.37M | -7.55M | -6.67M | -5.88M | -7.59M | -7.53M | -7.93M | -12.49M | -10.81M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -67.79% | -75.17% | -16.94% | -36.03% | -155.39% | -131.35% | -167.48% | -93.65% | -37.88% | -42.49% | -56.52% | 2.91% | -0.24% | 15.83% | 52.95% | 29.84% | 32.78% | 19.59% | -11.27% | 11.36% |
| FCF per Share | -0.52 | -0.45 | -0.37 | -0.30 | -0.42 | -0.34 | -0.39 | -0.22 | -0.19 | -0.22 | -0.21 | -0.17 | -0.17 | -0.28 | -0.26 | -0.41 | -0.41 | -0.43 | -0.68 | -0.68 |
| FCF Conversion (FCF/Net Income) | 1.51x | 0.62x | 0.60x | 0.74x | 0.91x | 0.76x | 1.58x | 0.65x | 0.71x | 0.72x | 1.02x | 0.88x | 1.16x | 0.71x | 0.71x | 0.86x | 0.84x | 0.87x | 0.73x | 0.86x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |